BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

238 related articles for article (PubMed ID: 7883578)

  • 1. Serum and urinary type IV collagen concentrations in the assessment of diabetic microangiopathy.
    Banu N; Hara H; Egusa G; Yamakido M
    Hiroshima J Med Sci; 1994 Dec; 43(4):123-33. PubMed ID: 7883578
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The meaning of serum levels of advanced glycosylation end products in diabetic nephropathy.
    Shimoike T; Inoguchi T; Umeda F; Nawata H; Kawano K; Ochi H
    Metabolism; 2000 Aug; 49(8):1030-5. PubMed ID: 10954022
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Plasma and urinary vascular endothelial growth factor and diabetic nephropathy in Type 2 diabetes mellitus.
    Kim NH; Kim KB; Kim DL; Kim SG; Choi KM; Baik SH; Choi DS; Kang YS; Han SY; Han KH; Ji YH; Cha DR
    Diabet Med; 2004 Jun; 21(6):545-51. PubMed ID: 15154937
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Influence of renal involvement on peripheral blood mononuclear cell expression behaviour of tumour necrosis factor-alpha and interleukin-6 in type 2 diabetic patients.
    Navarro JF; Mora C; Gómez M; Muros M; López-Aguilar C; García J
    Nephrol Dial Transplant; 2008 Mar; 23(3):919-26. PubMed ID: 17911088
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Urinary type IV collagen levels in diabetes mellitus.
    Sthaneshwar P; Chan SP
    Malays J Pathol; 2010 Jun; 32(1):43-7. PubMed ID: 20614725
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Plasma homocysteine and microvascular complications in type 1 diabetes.
    Vaccaro O; Perna AF; Mancini FP; Iovine C; Cuomo V; Sacco M; Tufano A; Rivellese AA; Ingrosso D; Riccardi G
    Nutr Metab Cardiovasc Dis; 2000 Dec; 10(6):297-304. PubMed ID: 11302003
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Serum cystatin C in diabetic patients. Not only an indicator for renal dysfunction in patients with overt nephropathy but also a predictor for cardiovascular events in patients without nephropathy.
    Ogawa Y; Goto T; Tamasawa N; Matsui J; Tando Y; Sugimoto K; Tomotsune K; Kimura M; Yasujima M; Suda T
    Diabetes Res Clin Pract; 2008 Feb; 79(2):357-61. PubMed ID: 17980929
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Association between homocysteinemia and renal function in patients with type 2 diabetes mellitus.
    Ozmen B; Ozmen D; Turgan N; Habif S; Mutaf I; Bayindir O
    Ann Clin Lab Sci; 2002; 32(3):279-86. PubMed ID: 12175091
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Serum and urinary concentrations of type IV collagen and laminin as a marker of microangiopathy in diabetes.
    Hayashi Y; Makino H; Ota Z
    Diabet Med; 1992 May; 9(4):366-70. PubMed ID: 1600709
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A novel advanced glycation index and its association with diabetes and microangiopathy.
    Sampathkumar R; Balasubramanyam M; Rema M; Premanand C; Mohan V
    Metabolism; 2005 Aug; 54(8):1002-7. PubMed ID: 16092048
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Association of haptoglobin phenotypes with markers of diabetic nephropathy in Type 2 diabetes mellitus.
    Awadallah SM; Saleh SA; Abu Shaqra QM; Hilow H
    J Diabetes Complications; 2008; 22(6):384-8. PubMed ID: 18413152
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Urinary excretion of type IV collagen and laminin in the evaluation of nephropathy in NIDDM: comparison with urinary albumin and markers of tubular dysfunction and/or damage.
    Banu N; Hara H; Okamura M; Egusa G; Yamakido M
    Diabetes Res Clin Pract; 1995 Jul; 29(1):57-67. PubMed ID: 8593760
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Urinary type IV collagen: a specific indicator of incipient diabetic nephropathy.
    Tan Y; Yang Y; Zhang Z; Zhang X; Zhang Z; Liu Y
    Chin Med J (Engl); 2002 Mar; 115(3):389-94. PubMed ID: 11940372
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Association between circulating monocyte chemoattractant protein-1 and urinary albumin excretion in nonobese Type 2 diabetic patients.
    Takebayashi K; Matsumoto S; Aso Y; Inukai T
    J Diabetes Complications; 2006; 20(2):98-104. PubMed ID: 16504838
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Urinary epidermal growth factor excretion is correlated to renal function loss per se and not to the degree of diabetic renal failure.
    ter Meulen CG; Bilo HJ; van Kamp GJ; Gans RO; Donker AJ
    Neth J Med; 1994 Jan; 44(1):12-7. PubMed ID: 8202200
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Urinary concentration of transforming growth factor-beta-inducible gene-h3(beta ig-h3) in patients with Type 2 diabetes mellitus.
    Cha DR; Kim IS; Kang YS; Han SY; Han KH; Shin C; Ji YH; Kim NH
    Diabet Med; 2005 Jan; 22(1):14-20. PubMed ID: 15606685
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Urinary glycosaminoglycans in patients with non-insulin-dependent diabetes mellitus, collagen diseases and IgA nephropathy].
    Ueta I; Takamatsu K; Hashimoto K
    Nihon Jinzo Gakkai Shi; 1994 Feb; 36(2):138-45. PubMed ID: 8139146
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Association of urinary type IV collagen with GFR decline in young patients with type 1 diabetes.
    Morita M; Uchigata Y; Hanai K; Ogawa Y; Iwamoto Y
    Am J Kidney Dis; 2011 Dec; 58(6):915-20. PubMed ID: 21763044
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Urinary tumour necrosis factor-alpha excretion independently correlates with clinical markers of glomerular and tubulointerstitial injury in type 2 diabetic patients.
    Navarro JF; Mora C; Muros M; García J
    Nephrol Dial Transplant; 2006 Dec; 21(12):3428-34. PubMed ID: 16935891
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Serum or urinary concentration of type IV collagen in diabetics.
    Watanabe T; Negishi K; Katayama S; Ishii J; Kawazu S
    J Diabet Complications; 1991; 5(2-3):191-2. PubMed ID: 1770043
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.